Editor-in-Chief Prof Pedro Romero, Ludwig Center for Cancer Research, Switzerland
Section Editors Basic tumor immunology Prof Cornelis JM Melief, ISA Therapeutics BV, Netherlands Case reports Prof Alfred Zippelius, University Hospital Basel, Switzerland Clinical trials monitor Dr Leisha A Emens, Johns Hopkins University, USA Clinical/translational cancer immunotherapy Dr James L Gulley, National Cancer Institute, National Institutes of Health, USA Dr Douglas G McNeel, University of Wisconsin Carbone Cancer Center, USA Commentary/editorials Dr Christian Capitini, University of Wisconsin Madison, USA Guidelines and Consensus Statements Dr Robert L Ferris, University of Pittsburgh, USA Immunotherapy biomarkers Dr Ignacio Melero, University of Navarra, USA Reviews Dr Sandra Demaria, Weill Cornell Medical College, USA Prof Thomas F Gajewski, University of Chicago, USA Deputy Editors Basic tumor immunology Sjoerd H van der Burg, Leiden University Medical Center, Netherlands Immunotherapy biomarkers Kurt A Schalper, Yale School of Medicine, United States Clinical/translational cancer immunotherapy Claudia Palena, National Institutes of Health, United States Associate Editors Basic tumor immunology Dr Scott I Abrams, Roswell Park Cancer Institute, USA Prof Paul A Antony, University of Maryland, USA Dr Timothy NJ Bullock, University of Virginia, USA Prof Gennaro Ciliberto, IRCCS Istituto Nazionale Tumori, Italy Dr Jonathan L. Curry, MD Anderson Cancer Center, USA Dr Madhav V Dhodapkar, Yale University, USA Dr Norman M Greenberg, Atreca, USA Dr Arthur A Hurwitz, Agenus, USA Dr Masahisa Jinushi, Merck & Co., Inc., Japan Prof Khashayarsha Khazaie, Northwestern University, USA Dr Michelle Krogsgaard, New York University, USA Dr Maria Rescigno, European Institute of Oncology, Italy Dr Lillian Seu, Allogene Therapeutics, USA Dr Sjoerd H Van der Burg, Leiden University Medical Center, Netherlands Dr Andrew D Weinberg, Earle A. Chiles Research Institute, USA Case reports Dr Jack Bui, University of California San Diego, USA Dr Richard D. Carvajal, Columbia University Medical Center, USA Dr Matthew Hellmann, Memorial Sloan Kettering Cancer Center, USA Dr Heinz Laubli, University Hospital Basel, Switzerland Dr Steven H Lin, University of Texas MD Anderson Cancer Center, USA Prof Sebastian Kobold, Ludwig Maximilians University of Munich, Germany Prof Andreas Mackensen, University Hospital Erlangen, Germany Dr Olivier Michielin, University of Lausanne, Switzerland Dr Hiroyoshi Nishikawa, National Cancer Center, Japan Dr Max Topp, University of Würzburg, Germany Dr Michael von Bergwelt-Baildon, University of Cologne, Germany Dr Geoffrey R. Weiss, University of Virginia, USA Dr Hassane Zarour, University of Pittsburgh, USA Clinical trials monitor Dr Stephen Ansell, Mayo Clinic, USA Dr Jonathan Cebon, Ludwig Institute for Cancer Research, Australia Dr Tai-Tsang Chen, Columbia University; BMS, USA Dr Jolanda de Vries, Radboud University Nijmegen, Netherlands Dr Silvia Formenti, Weill Cornell Medical College, USA Dr Howard Kaufman, Rutgers Cancer Institute of New Jersey, USA Dr Larry Kwak, City of Hope, USA Dr Sherene Loi, Peter MacCallum Cancer Centre, Australia Dr Kunle Odunsi, Roswell Park Cancer Institute, USA Dr Michael Postow, Memorial Sloan-Kettering Cancer Center, USA Prof Peter Schmid, Imperial College London, United Kingdom Dr Hiroshi Shiku, Mie University Graduate School of Medicine, Japan Dr Daniel Speiser, Ludwig Institute for Cancer Research, Switzerland Dr Louis Weiner, Georgetown University Lombardi Cancer Center, USA Dr Yi-Long Wu, Guangdong General Hospital and Academy of Medical Sciences, China Dr Xiabo Ye, Johns Hopkins University School of Medicine, USA Clinical/translational cancer immunotherapy Dr Paolo A Ascierto, Istituto Nazionale Tumori Fondazione G. Pascale, Italy Dr Ernest C Borden, The Cleveland Clinic Foundation, USA Dr Lisa Butterfield, Parker Institute for Cancer Immunotherapy, USA Dr Lawrence Fong, University of California, San Francisco, USA Dr Nancy M Hardy, University of Maryland, USA Dr Christian S Hinrichs, National Cancer Institute, ETIB, USA Dr Pawel Kalinski, Roswell Park Comprehensive Cancer Institute, USA Dr Yutaka Kawakami, Keio University School of Medicine, Japan Dr Beatrix Kotlan, National Institute of Oncology, Hungary Dr Dung Le, Johns Hopkins University, USA Prof Alessandro Lugli, University of Bern, Switzerland Dr Michele Maio, University Hospital of Siena, Italy Dr Ravi A Madan, National Cancer Institute, National Institutes of Health, USA Prof Giorgio Parmiani, Fondazione C.S. Raffaele Del Monte Tabor, Italy Dr Anna C Pavlick, NYU Cancer Institute, USA Dr Padmanee Sharma, MD Anderson Cancer Center, USA Dr Jeffrey S Weber, NYU Langone Medical Center, USA Dr Cassian Yee, MD Anderson Cancer Center, USA Commentary/editorials Dr Ana Anderson, Harvard University, USA Prof Wolf-Hervé Fridman, Cordeliers Research Center, France Prof Bryon D Johnson, Medical College of Wisconsin, USA Dr William J Murphy, University of California, Davis, USA Dr Gabriel Rabinovich, Instituto de Biologia y Medicina Experimental, Argentina Dr William L Redmond, Earle A. Chiles Research Institute, USA Prof Paul M Sondel, University of Wisconsin, USA Guidelines and consensus statements Prof Paulo A. Ascierto, Istituto Nazional Tumori-Fondazione 'G.Pascale', Italy Dr Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, USA Dr Michael R. Bishop, University of Chicago, USA Prof Michael Platten, Ruprecht-Karls University Heidelberg, Germany Immunotherapy biomarkers Dr Luigi Buonaguro, Instituto Nazionale Tumori, IRCCs, Fondazione Pascale Napoli, Italy Dr Alessandra Cesano, Nanostring, Inc., USA Dr Alexandra Snyder Charen, Merck and Dohme Corp, USA Dr Priti Hegde, Genentech, USA Dr Michael Kalos, Janssen Oncology, USA Dr Thomas Kleen, Precision for Medicine, Germany Dr Rejean Lapointe, Universite De Montreal, University Hospital (CRCHUM), Canada Dr Christian H Ottensmeier, University of Southampton, UK Dr Licia Rivoltini, Fondazione IRCCS Istituto Nazionale Tumori, Italy Dr Kimberly A Shafer-Weaver, Merck & Co., USA Dr Kurt A Schalper, Yale School of Medicine, USA Dr Craig L Slingluff, University of Virginia, USA Dr Ena Wang, Allogene Therapeutics, USA Dr Jianda Yuan, Merck & Co., USA Reviews Dr Michael B Atkins, Georgetown-Lombardi Comprehensive Care Center, USA Dr Ira Mellman, Genentech, USA Dr James J Mule, H. Lee Moffitt Comprehensive Cancer Center, USA
|